[(1R,2S,5R,7S,9S,11R,12S,15S,17S,18S,19S)-2,12-diacetyloxy-9-ethenyl-17-hydroxy-15-[(2R,3S)-2-hydroxy-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]oxy-14,19,20,20-tetramethyl-4,8,10-trioxapentacyclo[9.7.1.113,17.02,5.07,19]icos-13-en-18-yl] benzoate | 942950-93-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: [(1R,2S,5R,7S,9S,11R,12S,15S,17S,18S,19S)-2,12-diacetyloxy-9-ethenyl-17-hydroxy-15-[(2R,3S)-2-hydroxy-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]oxy-14,19,20,20-tetramethyl-4,8,10-trioxapentacyclo[9.7.1.113,17.02,5.07,19]icos-13-en-18-yl] benzoate
• CAS: 942950-93-8
• 化学式: C₄₆H₆₃NO₁₅
• 分子量: 870.004
• InChiKey: FDTAUJJRHBRHIJ-IXZMDXKISA-N

物化性质

• 沸点：
  857.4±65.0 °C(Predicted)
• 密度：
  1.29±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  62
• 可旋转键数：
  17
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  212
• 氢给体数：
  3
• 氢受体数：
  15

反应信息

• 作为产物：
  描述：

  10-脱乙酰基巴卡丁 III 在 4-二甲氨基吡啶 、 palladium 10% on activated carbon 盐酸 、 4-二甲氨基吡啶 、 sodium tetrahydroborate 、 camphor-10-sulfonic acid 、 氢气 、 正己基锂 、 N-甲基吗啉氧化物 、 sodium sulfate 、 三乙胺 、 N,N'-二环己基碳二亚胺 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 正庚烷 、 二氯甲烷 、 甲基叔丁基醚 、 水 、 甲苯 为溶剂， 反应 122.25h， 生成 [(1R,2S,5R,7S,11R,12S,15S,17S,18S,19S)-2,12-diacetyloxy-9-ethenyl-17-hydroxy-15-[(2S,3S)-2-hydroxy-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]oxy-14,19,20,20-tetramethyl-4,8,10-trioxapentacyclo[9.7.1.113,17.02,5.07,19]icos-13-en-18-yl] benzoate 、 [(1R,2S,5R,7S,9S,11R,12S,15S,17S,18S,19S)-2,12-diacetyloxy-9-ethenyl-17-hydroxy-15-[(2R,3S)-2-hydroxy-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]oxy-14,19,20,20-tetramethyl-4,8,10-trioxapentacyclo[9.7.1.113,17.02,5.07,19]icos-13-en-18-yl] benzoate
  参考文献：
  名称：

  Biologically Active Taxane Analogs and Methods of Treatment

  摘要：

  本申请涉及新的紫杉醇类似物，包括这种类似物的药物组合物以及包括这种组合物的治疗癌症的方法。根据本申请的化合物具有一般公式：其中R1和R2分别选自H、烷基、烯基或芳基；R3是羟基或OP1；R4是OH或R7COO；R7是烷基、烯基或芳基，R8和R9分别独立选自H、烷基或烯基。本申请的化合物可能特别是通过以标准紫杉醇作为起始化合物开始的过程形成的9,10-α,α-OH紫杉醇类似物。

  公开号：

  US20080207743A1

文献信息

• Convergent Process for the Synthesis of Taxane Derivatives
  申请人：Henri John T.

  公开号：US20070225510A1

  公开（公告）日：2007-09-27

  The present invention is broadly directed to novel compounds useful for the synthesis of biologically active compounds, including taxane derivatives, and convergent processes for the preparation of these taxane derivatives and their intermediates.

  本发明广泛涉及用于合成生物活性化合物（包括紫杉醇衍生物）的新化合物，以及制备这些紫杉醇衍生物和它们的中间体的汇聚过程。
• CONVERGENT PROCESS FOR THE SYNTHESIS OF TAXANE DERIVATIVES.
  申请人：Henri John T.

  公开号：US20090306400A1

  公开（公告）日：2009-12-10

  The present invention is broadly directed to novel compounds useful for the synthesis of biologically active compounds, including taxane derivatives, and convergent processes for the preparation of these taxane derivatives and their intermediates.

  本发明广泛涉及用于合成生物活性化合物的新化合物，包括紫杉醇衍生物，以及制备这些紫杉醇衍生物和它们的中间体的汇合过程。
• TAXANE AND ABEO-TAXANE ANALOGS
  申请人：McChesney James D.

  公开号：US20150158880A1

  公开（公告）日：2015-06-11

  The present application discloses new taxane analogs, intermediates and methods for producing them. The present application is also directed to pharmaceutical formulations comprising abeo-taxanes and methods of treating cancer with the abeo-taxanes.

  本申请公开了新的紫杉醇类似物、中间体及其生产方法。本申请还涉及包含阿贝紫杉醇的药物配方和使用阿贝紫杉醇治疗癌症的方法。
• Biologically active taxane analogs and methods of treatment
  申请人：McChesney James D.

  公开号：US20080207744A1

  公开（公告）日：2008-08-28

  The present application relates to new taxane analogs, pharmaceutical compositions comprising such analogs and methods of treating cancer comprising such compositions. The compounds according to the present application have the general formula: wherein R 1 and R 2 are each selected from H, alkyl, alkenyl or aryl; R 3 is hydroxyl or OP 1 ; R 4 is OH or R 7 COO; R 7 is alkyl, alkenyl or aryl, R 8 and R 9 are each independently selected from H, alkyl or alkenyl. The compounds of the present application may particularly be 9,10-α,α-OH taxane analogs that are formed by a process starting with a standard taxane as the starting compound.
• US8912229B2
  申请人：——

  公开号：US8912229B2

  公开（公告）日：2014-12-16